Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | LDHA | P00338 | 2/20 | 0.46 |
| ▸ | LDHB | P07195 | 1/20 | 0.46 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 4/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.33 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.33 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL28903547 | 1.00 | CA1 (0.50) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL20338159 | 1.00 | CA1 (0.50) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL6691785 | 1.00 | CA1 (0.50) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL376974 | 1.00 | — | — | |
| Oxalic Acid SCHEMBL2566908 | 1.00 | CA1 (0.50) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL3399924 | 1.00 | CA1 (0.50) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL1396101 | 1.00 | — | — | |
| Oxalic Acid SCHEMBL1402346 | 1.00 | CA1 (0.50) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL6696050 | 1.00 | CA1 (0.50) | CA1CA2CA9LDHALDHB | |
| Oxalic Acid SCHEMBL15544038 | 1.00 | CA1 (0.50) | CA1CA2CA9LDHALDHB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114727916-B | Hair treatment composition comprising oil containing olefinically unsaturated hydrocarbon | 株式会社LG生活健康 | 2025-04-25 | — | — | CN | disclosed |
| CN-118603710-B | Application of oxalic acid and iron complex in melt dynamic nuclear polarization | 中国科学院精密测量科学与技术创新研究院 | 2024-12-03 | — | — | CN | disclosed |
| CN-118603710-A | Application of oxalic acid and iron complex in melt dynamic nuclear polarization | 中国科学院精密测量科学与技术创新研究院 | 2024-09-06 | — | — | CN | disclosed |
| CN-111712492-B | Cyclotriazoles as LPA antagonists | 百时美施贵宝公司 | 2024-05-31 | — | — | CN | disclosed |
| EP-3728224-B1 | CYCLOHEXYL ACID TRIAZOLE AZOLES AS LPA ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2023-01-11 | — | — | EP | disclosed |
| EP-4097100-A1 | 1H-PYRAZOLO[4,3-D]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS | Bristol-Myers Squibb Company (US) | 2022-12-07 | — | — | EP | disclosed |
| US-11319315-B2 | Cyclohexyl acid triazole azoles as LPA antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2022-05-03 | — | — | US | disclosed |
| WO-2021154666-A1 | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-08-05 | — | — | WO | disclosed |
| US-20210163470-A1 | CYCLOHEXYL ACID TRIAZOLE AZOLES AS LPA ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2021-06-03 | — | — | US | disclosed |
| EP-3728224-A1 | CYCLOHEXYL ACID TRIAZOLE AZOLES AS LPA ANTAGONISTS | Bristol-Myers Squibb Company (US) | 2020-10-28 | — | — | EP | disclosed |
| US-20130178668-A1 | Multifunctional Hydrogenation Catalysts | CELANESE INTERNATIONAL CORPORATION (US) | 2013-07-11 | — | — | US | disclosed |
| WO-2013056268-A2 | HYDROGENATION CATALYSTS PREPARED FROM POLYOXOMETALATE PRECURSORS AND PROCESS FOR USING SAME TO PRODUCE ETHANOL | CELANESE INTERNATIONAL CORPORATION (US) | 2013-04-18 | — | — | WO | disclosed |
| WO-2013052971-A2 | HYDROGENATION CATALYSTS PREPARED FROM POLYOXOMETALATE PRECURSORS AND PROCESS FOR USING SAME TO PRODUCE ETHANOL WHILE MINIMIZING DIETHYL ETHER FORMATION | CELANESE INTERNATIONAL CORPORATION (US) | 2013-04-11 | — | — | WO | disclosed |
| EP-1257377-A4 | RAPID CONVERSION OF METAL-CONTAINING COMPOUNDS TO FORM METALS OR METAL OXIDES | OMG AMERICAS INC (US) | 2004-04-21 | — | — | EP | disclosed |
| US-6689191-B2 | DECOMPOSITION, OXIDATION, AND REDUCTION; CAN BE SIMULTANEOUS | OMG AMERICAS, INC. | 2004-02-10 | — | — | US | disclosed |
| US-20030230169-A1 | Rapid conversion of metal-containing compounds to form metal oxides | DUNMEAD STEPHEN (US) | 2003-12-18 | — | — | US | disclosed |
| CN-1419482-A | Rapid conversion of metal-containing compounds to form metals or metal oxides | OMG AMERICAS INC (US) | 2003-05-21 | — | — | CN | disclosed |
| US-20030019328-A1 | Rapid conversion of metal-containing compounds to form metals or metal oxides | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2003-01-30 | — | — | US | disclosed |
| EP-1257377-A1 | RAPID CONVERSION OF METAL-CONTAINING COMPOUNDS TO FORM METALS OR METAL OXIDES | OMG Americas, Inc. (US) | 2002-11-20 | — | — | EP | disclosed |
| WO-2001062421-A1 | RAPID CONVERSION OF METAL-CONTAINING COMPOUNDS TO FORM METALS OR METAL OXIDES | OMG AMERICAS, INC. (US) | 2001-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319315-B2 | Cyclohexyl acid triazole azoles as LPA antagonists | LPAR3, LPAR1, LPAR2 | CA1 2452/4885CA2 1139/4885CA9 1798/4885 |
| US-20210163470-A1 | CYCLOHEXYL ACID TRIAZOLE AZOLES AS LPA ANTAGONISTS | LPAR3, LPAR1, LPAR2 | CA1 2452/4885CA2 1139/4885CA9 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.